Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
The 18-year-old, Chirag Chikkara clinched a gold medal in the men’s freestyle 57kg categ
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
- Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow
- FIFA : Over 100 female footballers urge FIFA to reconsider partnership with Saudi oil giant
- Ecuador ready to make history against Uruguay: Beccacece
- Divanshi wins second gold as India sweep women's 25m standard pistol at Lima Junior Worlds
Novel way for weight loss in patients with obesity, diabetes Last Updated : 14 Jan 2021 01:09:02 PM IST Researchers have found that treatment with Bimagrumab is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and Type-2 diabetes.
Bimagrumab is an antibody that blocks activ in type II receptors and stimulates skeletal muscle growth."These exciting results suggest that there may be a novel mechanism for achieving weight loss with a profound loss of body fat and an increase in lean mass, along with other metabolic benefits," said researcher Steve Heymsfield from Pennington Biomedical Research Center, in the US.For the study, published in the JAMA Network Open journal, a total of 75 patients with Type-2 diabetes, body mass index between 28 and 40 and glycated hemoglobin A1c levels between 6.5 percent and 10 per cent were selected for the phase 2 randomized clinical trial.APatients were injected with either Bimagrumab or a placebo (a dextrose solution) every 4 weeks for 48 weeks. Both groups received diet and exercise counselling.At the end of the 48-week study, researchers found a nearly 21 per cent decrease in body fat in the Bimagrumab group compared to 0.5 percent in the placebo group.The results also revealed the Bimagrumab group gained 3.6 percent of lean mass compared with a loss of 0.8 per cent in the placebo group.The combined loss in total body fat and gain in lean mass led to a net 6.5 per cent reduction in body weight in patients receiving Bimagrumab compared with 0.8 per cent weight loss in their counterparts receiving the placebo.IANS New York For Latest Updates Please-
Join us on
Follow us on
172.31.16.186